Gunderson Capital Management’s Novo Nordisk NVO Stock Holding History

Gunderson Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.27M	Sell	68,179 -1,032	-1%	-$44.3K	0.88%	34
2026 Q1	$2.54M	Buy	+69,211	New	+$3.28M	1.06%	35
2024 Q4	–	Sell	-107,678	Closed	-$12.8M	–	45
2024 Q3	$12.8M	Sell	107,678 -79	-0.1%	-$10.5K	5.43%	4
2024 Q2	$15.4M	Buy	107,757 +22,204	+26%	+$2.94M	6.6%	2
2024 Q1	$11M	Buy	85,553 +6,505	+8%	+$774K	5.1%	5
2023 Q4	$8.18M	Buy	79,048 +11,590	+17%	+$1.15M	4.67%	5
2023 Q3	$6.13M	Sell	67,458 -1,402	-2%	-$124K	4.17%	9
2023 Q2	$5.57M	Sell	68,860 -4,458	-6%	-$364K	3.68%	11
2023 Q1	$5.83M	Buy	+73,318	New	+$5.2M	4.33%	10

Other funds holding NVO

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

AIIMS

Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

GIM

Generate Investment Management Auckland, New Zealand $2.43B AUM 37.24% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return

OFA

Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return

Gunderson Capital Management's NVO Position: Q2 2026 in Review

Gunderson Capital Management reduced its Novo Nordisk (NVO) stake by 1.5% in Q2 2026, selling an estimated $44.3K and leaving 68,179 shares worth $3.27M. The position accounts for 0.88% of the portfolio, ranked #34.

Gunderson Capital Management first reported a position in NVO in Q1 2023 and has held it in 9 quarters since. The position peaked at $15.4M in Q2 2024. 516 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Gunderson Capital Management held 68,179 shares of Novo Nordisk worth $3.27M as of Q2 2026.
Gunderson Capital Management sold 1,032 Novo Nordisk shares in Q2 2026, an estimated $44.3K.
Novo Nordisk made up 0.88% of Gunderson Capital Management's portfolio in Q2 2026, its #34 holding.
Gunderson Capital Management first reported a position in Novo Nordisk in Q1 2023 and has held it in 9 quarters since.
Gunderson Capital Management's Novo Nordisk position peaked at $15.4M in Q2 2024.
516 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Gunderson Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.